Diabetes in Midlife and Cognitive Change Over 20 Years A Cohort Study

被引:322
作者
Rawlings, Andreea M.
Sharrett, A. Richey
Schneider, Andrea L. C.
Coresh, Josef
Albert, Marilyn
Couper, David
Griswold, Michael
Gottesman, Rebecca F.
Wagenknecht, Lynne E.
Windham, B. Gwen
Selvin, Elizabeth
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
[5] Wake Forest Univ, Winston Salem, NC 27109 USA
关键词
VASCULAR RISK-FACTORS; BLOOD-PRESSURE; APOE GENOTYPE; UNITED-STATES; DEMENTIA; DECLINE; GLUCOSE; ATTRITION; MELLITUS; DISEASE;
D O I
10.7326/M14-0737
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Type 2 diabetes is associated with dementia risk, but evidence is limited for possible associations of diabetes and prediabetes with cognitive decline. Objective: To determine whether diabetes in midlife is associated with 20-year cognitive decline and to characterize long-term cognitive decline across clinical categories of hemoglobin A(1c) (HbA(1c)) levels. Design: Prospective cohort study. Setting: The community-based ARIC (Atherosclerosis Risk in Communities) study. Participants: 13 351 black and white adults aged 48 to 67 years at baseline (1990 to 1992). Measurements: Diabetes was defined by self-reported physician diagnosis or medication use or HbA1c level of 6.5% or greater. Undiagnosed diabetes, prediabetes, and glucose control in persons with diagnosed diabetes were defined by clinical categories of HbA1c level. Delayed word recall, digit symbol substitution, and word fluency tests were used to assess cognitive performance and were summarized with a global Z score. Results: Diabetes in midlife was associated with a 19% greater cognitive decline over 20 years ( adjusted global Z-score difference, -0.15 [95% CI, -0.22 to -0.08]) compared with no diabetes. Cognitive decline was significantly greater among persons with prediabetes (HbA1c level of 5.7% to 6.4%) than among those with an HbA1c level less than 5.7%. Participants with poorly controlled diabetes (HbA1c level >= 7.0%) had greater decline than those whose diabetes was controlled (adjusted global Z-score difference, -0.16; P = 0.071). Longer-duration diabetes was also associated with greater late-life cognitive decline (P for trend < 0.001). Rates of decline did not differ significantly between white and black persons (P for interaction = 0.44). Limitation: Single HbA(1c) measurement at baseline, 1 test per cognitive domain, and potential geographic confounding of race comparisons. Conclusion: Diabetes prevention and glucose control in midlife may protect against late-life cognitive decline.
引用
收藏
页码:785 / U68
页数:17
相关论文
共 39 条
[1]   Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study [J].
Alonso, A. ;
Mosley, T. H., Jr. ;
Gottesman, R. F. ;
Catellier, D. ;
Sharrett, A. R. ;
Coresh, J. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11) :1194-1201
[2]   Standards of Medical Care in Diabetes-2014 [J].
不详 .
DIABETES CARE, 2014, 37 :S14-S80
[3]   APOE Genotype Modifies the Relationship between Midlife Vascular Risk Factors and Later Cognitive Decline [J].
Bangen, Katherine J. ;
Beiser, Alexa ;
Delano-Wood, Lisa ;
Nation, Daniel A. ;
Lamar, Melissa ;
Libon, David J. ;
Bondi, Mark W. ;
Seshadri, Sudha ;
Wolf, Philip A. ;
Au, Rhoda .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (08) :1361-1369
[4]  
Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646
[5]  
Benton A., 1989, MULTILINGUAL APHASIA
[6]   Risk of dementia in diabetes mellitus: a systematic review [J].
Biessels, GJ ;
Staekenborg, S ;
Brunner, E ;
Brayne, C ;
Scheltens, P .
LANCET NEUROLOGY, 2006, 5 (01) :64-74
[7]   Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset [J].
Brookmeyer, R ;
Gray, S ;
Kawas, C .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (09) :1337-1342
[8]   Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies [J].
Cheng, G. ;
Huang, C. ;
Deng, H. ;
Wang, H. .
INTERNAL MEDICINE JOURNAL, 2012, 42 (05) :484-491
[9]   Diabetic retinopathy [J].
Cheung, Ning ;
Mitchell, Paul ;
Wong, Tien Yin .
LANCET, 2010, 376 (9735) :124-136
[10]   Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study [J].
Christman, A. L. ;
Matsushita, K. ;
Gottesman, R. F. ;
Mosley, T. ;
Alonso, A. ;
Coresh, J. ;
Hill-Briggs, F. ;
Sharrett, A. R. ;
Selvin, E. .
DIABETOLOGIA, 2011, 54 (07) :1645-1652